Postpartum depression may persist three years after giving birth
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
On Oct. 27, 2020, researchers from the National Institutes of Health (NIH) announced they had discovered a new…
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
On Oct. 27, 2020, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Oct. 27, 2020, Novavax announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19…
On Oct. 27, 2020, CHF Solutions announced that it had shipped Aquadexル product to medical facilities in Tennessee…
On Oct. 26, 2020, the Department of Defense (DOD), in coordination with the Department of Health and Human…
On Aug. 27, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
On Oct. 26, 2020, BioSig Technologies and its majority owned subsidiary, ViralClear Pharmaceuticals, announced the halting of its…
On Oct. 26, 2020, Moderna announced a supply agreement with the Ministry of Public Health of Qatar for…
On Oct. 26, 2020, PerkinElmer announced that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel had received clearance to be…
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
On Oct. 26, 2020, ContraFect announced that it had initiated an expanded access program to provide exebacase for…
On Oct. 26, 2020, Todos Medical announced the completion of the instrument validation in its mobile lab division….
On Oct. 26, 2020, Taconic Biosciences announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2…
On Oct. 26, 2020, Membrion announced a breakthrough in the fight against the COVID-19 virus: a molecular coating…
On Oct. 26, 2020, Todos Medical announced the completion of clinical validation and CLIA certification for MOTO+PARA’s mobile…
On Oct. 23, 2020, Entos Pharmaceuticals announced it was receiving advisory services and funding of up to $5…
On Oct. 23, 2020, the U.S. FDA authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford…
On Oct. 23, 2020, NIH researchers reported that the plant compound apigenin improved the cognitive and memory deficits…
On Oct. 23, 2020, CureVac announced data from preclinical studies of its investigational SARS-CoV-2 vaccine candidate, CVnCoV, in…
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
On Oct. 23, 2020, Johnson & Johnson announced that it was preparing to resume recruitment in the pivotal…
On Oct. 22, 2020, a newly developed light-sensing protein called the MCO1 opsin restored vision in blind mice…
On Oct. 22, 2020, the World Health Organization (WHO) and the Wikimedia Foundation announced a collaboration to expand…
On Oct. 22, 2020, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges,…
On Oct. 22, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a Collaboration…
On Oct. 22, 2020, Todos Medical announced that it had entered into an exclusive supply agreement with U.S….